Answers are grounded in this paper and cite their sources.
Resistance has emerged to artemisinin, the backbone of combination therapy for the treatment of Plasmodium falciparum malaria. This week in the Journal, Ménard et al. present a global map of artemisinin genotypic resistance to inform strategies for the control and treatment of malaria.1 Artemisinin filled a critical gap created by chloroquine resistance and was designated more than a decade ago by the World Health Organization (WHO) as the drug of choice to be used in combination for malaria treatment.2 Artemisinin is the most effective drug for severe malaria.3 Furthermore, in addition to clearing the disease-causing asexual blood stages, artemisinin also . . .
No takes yet. Share an insight, caveat, or question.
Johanna P. Daily (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: